Search earnings tickers

REGN

2025Q4BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-01-30 · Fiscal end 2025-12-31 · Features as of 2026-01-29

← Earnings history

Street

Consensus EPS10.75

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.2%

IV front—

P/C full—

P/C front—

Features as of2026-01-29

Run-up

Close—

Ret 5d-0.8%

Ret 10d-0.6%

Ret 20d-3.2%

Ret 30d-0.4%

Print

Actual EPS

11.44Beat

Estimated EPS10.75

Actual revenue

3.9B

Surprise %+6.4%

Beat / missBeat

Beat streak 43

Beat streak 83

Reaction

1-day stock reaction-1.7%

Implied vs actual

Implied 2.2%Actual 0.6%

Gap reaction+0.6%

Day result-1.1%

Next-day upNo

Realized / IV0.27×

Post tape

Post 5d+5.9%

Post 10d+8.3%

Post volume1.3M

Vol ×10d1.47×

Vol ×20d1.51×

Post range5.1%